New ADHD drug shows promise for kids in Late-Stage trial
NCT ID NCT05286762
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new medication called CTx-1301 (dexmethylphenidate) for children and teens aged 6 to 17 with ADHD. The goal was to see if it reduces ADHD symptoms better than a placebo. 103 participants took either the drug or a placebo, and researchers measured changes in ADHD rating scales and overall severity. The trial is now complete.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADHD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Access Clinical Trials Inc.
Nashville, Tennessee, 37203, United States
-
Atlanta Center for Medical Research
Atlanta, Georgia, 30331, United States
-
BioBehavioral Research of Austin
Austin, Texas, 78759, United States
-
Center for Psychiatry and Behavioral Medicine. Inc.
Las Vegas, Nevada, 89128, United States
-
Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida, 32256, United States
-
Clinical Neuroscience Solutions, Inc.
Orlando, Florida, 32801, United States
-
Clinical Neuroscience Solutions, Inc.
Memphis, Tennessee, 38119, United States
-
Clinical Research Partners LLC
Petersburg, Virginia, 23805, United States
-
Coastal Carolina Research Center
North Charleston, South Carolina, 29405, United States
-
Coastal Pediatric Associates
Charleston, South Carolina, 29414, United States
-
Dayton Clinical Research
Dayton, Ohio, 45409, United States
-
Family Psychiatry of The Woodlands
Woodland, Texas, 77381, United States
-
FutureSearch Trials
Dallas, Texas, 75231, United States
-
Gadolin Research
Beaumont, Texas, 77702, United States
-
Hassman Research Institute
Berlin, New Jersey, 08009, United States
-
Houston Clinical Trials
Bellaire, Texas, 77401, United States
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
-
Meridien Research
Maitland, Florida, 32751, United States
-
Neurobehavioral Medicine Group
Bloomfield Hills, Michigan, 48302, United States
-
Red Oak Psychiatry Associates, PA
Houston, Texas, 77090, United States
-
SP Research PLLC
Oklahoma City, Oklahoma, 73112, United States
-
Sisu Bhr, Llc
Springfield, Massachusetts, 01103, United States
-
St Charles Psychiatric Associates & Midwest Research Group
Saint Charles, Missouri, 63304, United States
-
Summit Research Network, LLC
Portland, Oregon, 97210, United States